These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 21005353)

  • 21. Further observations on 17D-yellow fever vaccination by scarification, with and without simultaneous smallpox vaccination.
    MEERS PD
    Trans R Soc Trop Med Hyg; 1960 Sep; 54():493-501. PubMed ID: 13768949
    [No Abstract]   [Full Text] [Related]  

  • 22. Vaccines and vaccination against yellow fever. WHO position paper -- June 2013.
    Wkly Epidemiol Rec; 2013 Jul; 88(27):269-83. PubMed ID: 23909008
    [No Abstract]   [Full Text] [Related]  

  • 23. Reactions following neurotropic yellow fever vaccine given by scarification in Nigeria.
    MACNAMARA FN
    Trans R Soc Trop Med Hyg; 1953 May; 47(3):199-208. PubMed ID: 13077718
    [No Abstract]   [Full Text] [Related]  

  • 24. Mathematical modeling provides kinetic details of the human immune response to vaccination.
    Le D; Miller JD; Ganusov VV
    Front Cell Infect Microbiol; 2014; 4():177. PubMed ID: 25621280
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Immunization against yellow fever].
    Landry P; Genton B
    Rev Med Suisse; 2007 May; 3(111):1237-40. PubMed ID: 17585627
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recent immunization against measles does not interfere with the sero-response to yellow fever vaccine.
    Stefano I; Sato HK; Pannuti CS; Omoto TM; Mann G; Freire MS; Yamamura AM; Vasconcelos PF; Oselka GW; Weckx LW; Salgado MF; Noale LF; Souza VA
    Vaccine; 1999 Mar; 17(9-10):1042-6. PubMed ID: 10195613
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serologic assessment of yellow fever immunity in the rural population of a yellow fever-endemic area in Central Brazil.
    Machado VW; Vasconcelos PF; Silva EV; Santos JB
    Rev Soc Bras Med Trop; 2013; 46(2):166-71. PubMed ID: 23740066
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Is the absence or intermittent YF vaccination the major contributor to its persistent outbreaks in eastern Africa?
    Baba MM; Ikusemoran M
    Biochem Biophys Res Commun; 2017 Oct; 492(4):548-557. PubMed ID: 28109882
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reduction of yellow fever virus mouse neurovirulence by immunization with a bacterially synthesized non-structural protein (NS1) fragment.
    Cane PA; Gould EA
    J Gen Virol; 1988 Jun; 69 ( Pt 6)():1241-6. PubMed ID: 3133449
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protection of mice against yellow fever virus encephalitis by immunization with a vaccinia virus recombinant encoding the yellow fever virus non-structural proteins, NS1, NS2a and NS2b.
    Putnak JR; Schlesinger JJ
    J Gen Virol; 1990 Aug; 71 ( Pt 8)():1697-702. PubMed ID: 2144016
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Yellow fever vaccination by scarification with 17D vaccine.
    DE ROEVER-BONNET H; HOEKSTRA J
    Trop Geogr Med; 1958 Sep; 10(3):289-91. PubMed ID: 13603603
    [No Abstract]   [Full Text] [Related]  

  • 32. CHRONOVAC VOYAGEUR: A study of the immune response to yellow fever vaccine among infants previously immunized against measles.
    Goujon C; Gougeon ML; Tondeur L; Poirier B; Seffer V; Desprès P; Consigny PH; Vray M;
    Vaccine; 2017 Oct; 35(45):6166-6171. PubMed ID: 28958813
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The 17D-204 and 17DD yellow fever vaccines: an overview of major similarities and subtle differences.
    Ferreira CC; Campi-Azevedo AC; Peruhype-Magalhāes V; Costa-Pereira C; Albuquerque CP; Muniz LF; Yokoy de Souza T; Oliveira ACV; Martins-Filho OA; da Mota LMH
    Expert Rev Vaccines; 2018 Jan; 17(1):79-90. PubMed ID: 29172832
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A recombinant Yellow Fever 17D vaccine expressing Lassa virus glycoproteins.
    Bredenbeek PJ; Molenkamp R; Spaan WJ; Deubel V; Marianneau P; Salvato MS; Moshkoff D; Zapata J; Tikhonov I; Patterson J; Carrion R; Ticer A; Brasky K; Lukashevich IS
    Virology; 2006 Feb; 345(2):299-304. PubMed ID: 16412488
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunity to yellow fever 6 years after vaccination.
    DICK GW; SMITHBURN KC
    Am J Trop Med Hyg; 1949 Jan; 29(1):57-61. PubMed ID: 18110333
    [No Abstract]   [Full Text] [Related]  

  • 36. The distribution of immunity to yellow fever in Central and East Africa.
    MAHAFFY AF; SMITHBURN KC; HUGHES TP
    Trans R Soc Trop Med Hyg; 1946 Aug; 40():57-82. PubMed ID: 20998611
    [No Abstract]   [Full Text] [Related]  

  • 37. Yellow fever vaccination - Once in a lifetime?
    Grobusch MP; van Aalst M; Goorhuis A
    Travel Med Infect Dis; 2017; 15():1-2. PubMed ID: 28013052
    [No Abstract]   [Full Text] [Related]  

  • 38. Shortage of vaccines during a yellow fever outbreak in Guinea.
    Nathan N; Barry M; Van Herp M; Zeller H
    Lancet; 2001 Dec 22-29; 358(9299):2129-30. PubMed ID: 11784630
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neutralizing (54K) and non-neutralizing (54K and 48K) monoclonal antibodies against structural and non-structural yellow fever virus proteins confer immunity in mice.
    Gould EA; Buckley A; Barrett AD; Cammack N
    J Gen Virol; 1986 Mar; 67 ( Pt 3)():591-5. PubMed ID: 3950582
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Duration of post-vaccination humoral immunity against yellow fever in children.
    de Noronha TG; de Lourdes de Sousa Maia M; Geraldo Leite Ribeiro J; Campos Lemos JA; Maria Barbosa de Lima S; Martins-Filho OA; Campi-Azevedo AC; da Silva Freire M; de Menezes Martins R; Bastos Camacho LA;
    Vaccine; 2019 Nov; 37(48):7147-7154. PubMed ID: 31590934
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.